Context Therapeutics Inc.
CNTX • NASDAQ • Stock Fundamentals
Context Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Martin A. Lehr, with a market cap of $130.5M.
Market Cap$130.5M
Employees9.0
CEOMartin A. Lehr
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Context Therapeutics Inc. FAQ
Common questions about Context Therapeutics Inc.
Context Therapeutics Inc. (CNTX) has a market capitalization of $130.5M and trades on NASDAQ.
Context Therapeutics Inc. has approximately 9 employees.